Bausch Health
BHC
#3606
Rank
A$4.50 B
Marketcap
$12.27
Share price
2.00%
Change (1 day)
3.46%
Change (1 year)
Bausch Health is a Canadian company that researches, develops and produces pharmaceuticals and markets patented drugs, generics and non-prescription drugs in the areas of dermatology and ophthalmology.

EPS for Bausch Health (BHC)

EPS in 2023 (TTM): -$4.00

According to Bausch Health 's latest financial reports the company's current EPS (TTM) is -$3.99. In 2022 the company made an earnings per share (EPS) of -$0.93 an increase over its 2021 EPS that were of -$3.99.

EPS history for Bausch Health from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$4.00330%
2022-$0.93-76.64%
2021-$3.9968.45%
2020-$2.37-68.91%
2019-$7.61-57.11%
2018-$17.75-272.22%
2017$10.31-199.29%
2016-$10.38798.7%
2015-$1.15-128.31%
2014$4.08-204.62%
2013-$3.90602.7%
2012-$0.55-171.15%
2011$0.78-143.96%
2010-$1.77-206.57%
2009$1.66-11.2%
2008$1.872.46%
2007$1.83-7.58%
2006$1.98-14.29%
2005$2.3154%
2004$1.50-500%
2003-$0.37-141.67%
2002$0.90-4.76%
2001$0.94-175%
2000-$1.26-268%
1999$0.7514.94%
1998$0.6520.83%
1997$0.5453.83%
1996$0.35

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$1.50-62.37%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.40-89.84%๐Ÿ‡บ๐Ÿ‡ธ USA